Ultralife Corporation
ULBI
$6.94
$0.040.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 187.86M | 191.16M | 186.53M | 178.85M | 173.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 187.86M | 191.16M | 186.53M | 178.85M | 173.28M |
| Cost of Revenue | 144.45M | 145.06M | 141.89M | 135.15M | 129.63M |
| Gross Profit | 43.41M | 46.10M | 44.64M | 43.71M | 43.65M |
| SG&A Expenses | 27.00M | 27.23M | 26.36M | 25.06M | 23.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.41M | 182.69M | 178.24M | 169.44M | 162.36M |
| Operating Income | 5.45M | 8.47M | 8.29M | 9.41M | 10.91M |
| Income Before Tax | -11.51M | -8.40M | 2.30M | 4.41M | 7.14M |
| Income Tax Expenses | -3.21M | -2.45M | 568.00K | 1.15M | 1.76M |
| Earnings from Continuing Operations | -8.30 | -5.95 | 1.74 | 3.26 | 5.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 87.00K | 53.00K | -17.00K | -65.00K | -98.00K |
| Net Income | -8.21M | -5.90M | 1.72M | 3.20M | 5.29M |
| EBIT | 5.45M | 8.47M | 8.29M | 9.41M | 10.91M |
| EBITDA | 10.92M | 13.97M | 13.66M | 14.36M | 15.46M |
| EPS Basic | -0.49 | -0.35 | 0.10 | 0.19 | 0.32 |
| Normalized Basic EPS | 0.14 | 0.23 | 0.17 | 0.23 | 0.32 |
| EPS Diluted | -0.50 | -0.36 | 0.10 | 0.19 | 0.32 |
| Normalized Diluted EPS | 0.14 | 0.23 | 0.16 | 0.23 | 0.32 |
| Average Basic Shares Outstanding | 66.59M | 66.57M | 66.54M | 66.52M | 66.46M |
| Average Diluted Shares Outstanding | 66.61M | 66.64M | 66.74M | 66.97M | 67.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |